Nelfinavir and Lenalidomide/Dexamethasone in Patients With Progressive Multiple Myeloma That Have Failed Lenalidomide-containing Therapy - A Single Arm Phase I/II Trial
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 16 Aug 2018
At a glance
- Drugs Nelfinavir (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
- 20 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 01 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.